Personal
Become a Client
CymaBay Therapeutics Inc (USD)
CBAY
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range4.58 | 4.89
52-Wk Range- | -
Last Close4.63
Mkt Cap (m)319.45
Dividend yield-
ISINUS23257D1037
Volume835,390.00
Exchange VenueNAS

Company Profile

CymaBay Therapeutics Inc is an American biotechnology enterprise. Its product candidates include Arhalofenate, MBX-8025, and MBX-2982, which are meant to combat serious metabolic diseases.

Key Information
Price/Earning-
Price/Book2.50
Price/Sales-
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-30.99
Debt/Equity0.01

Documents

Prospectus
en 14/07/2020
Annual Report
en 31/12/2020

Please refer to the below issuer website for further documents.

http://www.cymabay.com

Financials

Income Statement
USD201520162017201820192020
Revenue (m)0.000.0010.000.000.000.00
Operating Income (m)-25.90-25.59-21.33-72.51-103.08-53.31
Net Income (m)-15.53-26.67-27.56-72.55-102.81-50.99
Basic EPS-0.82-1.14-0.79-1.25-1.53-0.74
Avg. Diluted Shares Outstanding (m)18.9223.4534.9057.8467.0368.89
Balance Sheet
USD201520162017201820192020
Current Assets (m)42.7918.53103.54181.56202.92151.59
Non Current Assets (m)0.290.830.705.192.802.24
Total Assets (m)43.0819.36104.25186.75205.73153.83
Current Liabilities (m)6.159.3116.3114.4217.649.86
Total Liabilities (m)------
Total Equity (m)28.123.9484.95170.42186.35142.71
Cash Flows
USD201520162017201820192020
Operating Cash Flows (m)-23.32-23.35-19.63-54.94-97.91-44.73
Capital Expenditure (m)--0.04-0.03-0.53-0.32-0.02
Figures are quoted in USD unless stated otherwise
-
No change
$
4.63
Last Price

© 2021 MeDirect Bank (Malta) plc. All rights reserved.
MeDirect Bank (Malta) plc, company registration number C34125, is licensed to undertake the business of banking in terms of the Banking Act (Cap. 371) and investment services under the Investment Services Act (Cap. 370). MeDirect Bank (Malta) plc is regulated by the Malta Financial Services Authority as a Credit Institution under the Banking Act 1994.